175 related articles for article (PubMed ID: 10222137)
1. An inhibitor of nuclear export activates the p53 response and induces the localization of HDM2 and p53 to U1A-positive nuclear bodies associated with the PODs.
Laín S; Midgley C; Sparks A; Lane EB; Lane DP
Exp Cell Res; 1999 May; 248(2):457-72. PubMed ID: 10222137
[TBL] [Abstract][Full Text] [Related]
2. Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6.
Freedman DA; Levine AJ
Mol Cell Biol; 1998 Dec; 18(12):7288-93. PubMed ID: 9819415
[TBL] [Abstract][Full Text] [Related]
3. Activation of p53 in cervical carcinoma cells by small molecules.
Hietanen S; Lain S; Krausz E; Blattner C; Lane DP
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8501-6. PubMed ID: 10900010
[TBL] [Abstract][Full Text] [Related]
4. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein.
Roth J; Dobbelstein M; Freedman DA; Shenk T; Levine AJ
EMBO J; 1998 Jan; 17(2):554-64. PubMed ID: 9430646
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the activity, sequence specificity, and CRM1-dependence of different nuclear export signals.
Henderson BR; Eleftheriou A
Exp Cell Res; 2000 Apr; 256(1):213-24. PubMed ID: 10739668
[TBL] [Abstract][Full Text] [Related]
6. Nuclear and cytoplasmic degradation of endogenous p53 and HDM2 occurs during down-regulation of the p53 response after multiple types of DNA damage.
Joseph TW; Zaika A; Moll UM
FASEB J; 2003 Sep; 17(12):1622-30. PubMed ID: 12958168
[TBL] [Abstract][Full Text] [Related]
7. UV-radiation induces dose-dependent regulation of p53 response and modulates p53-HDM2 interaction in human fibroblasts.
Latonen L; Taya Y; Laiho M
Oncogene; 2001 Oct; 20(46):6784-93. PubMed ID: 11709713
[TBL] [Abstract][Full Text] [Related]
8. An intact HDM2 RING-finger domain is required for nuclear exclusion of p53.
Boyd SD; Tsai KY; Jacks T
Nat Cell Biol; 2000 Sep; 2(9):563-8. PubMed ID: 10980695
[TBL] [Abstract][Full Text] [Related]
9. MEK-ERK signaling controls Hdm2 oncoprotein expression by regulating hdm2 mRNA export to the cytoplasm.
Phelps M; Phillips A; Darley M; Blaydes JP
J Biol Chem; 2005 Apr; 280(17):16651-8. PubMed ID: 15723837
[TBL] [Abstract][Full Text] [Related]
10. A small synthetic peptide, which inhibits the p53-hdm2 interaction, stimulates the p53 pathway in tumour cell lines.
Chène P; Fuchs J; Bohn J; García-Echeverría C; Furet P; Fabbro D
J Mol Biol; 2000 May; 299(1):245-53. PubMed ID: 10860736
[TBL] [Abstract][Full Text] [Related]
11. Abundant expression of spliced HDM2 in Hodgkin lymphoma cells does not interfere with p14(ARF) and p53 binding.
Stürzenhofecker B; Schlott T; Quentin T; Kube D; Jung W; Trümper L
Leuk Lymphoma; 2003 Sep; 44(9):1587-96. PubMed ID: 14565663
[TBL] [Abstract][Full Text] [Related]
12. Cocompartmentalization of p53 and Mdm2 is a major determinant for Mdm2-mediated degradation of p53.
Xirodimas DP; Stephen CW; Lane DP
Exp Cell Res; 2001 Oct; 270(1):66-77. PubMed ID: 11597128
[TBL] [Abstract][Full Text] [Related]
13. HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 function.
Lau LM; Nugent JK; Zhao X; Irwin MS
Oncogene; 2008 Feb; 27(7):997-1003. PubMed ID: 17700533
[TBL] [Abstract][Full Text] [Related]
14. Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53.
Tao W; Levine AJ
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):3077-80. PubMed ID: 10077639
[TBL] [Abstract][Full Text] [Related]
15. Nuclear degradation of p53 occurs during down-regulation of the p53 response after DNA damage.
Shirangi TR; Zaika A; Moll UM
FASEB J; 2002 Mar; 16(3):420-2. PubMed ID: 11790725
[TBL] [Abstract][Full Text] [Related]
16. Study of the cytotoxic effect of a peptidic inhibitor of the p53-hdm2 interaction in tumor cells.
Chène P; Fuchs J; Carena I; Furet P; García-Echeverría C
FEBS Lett; 2002 Oct; 529(2-3):293-7. PubMed ID: 12372616
[TBL] [Abstract][Full Text] [Related]
17. Nuclear exclusion of p53 in a subset of tumors requires MDM2 function.
Lu W; Pochampally R; Chen L; Traidej M; Wang Y; Chen J
Oncogene; 2000 Jan; 19(2):232-40. PubMed ID: 10645001
[TBL] [Abstract][Full Text] [Related]
18. Blockage of CRM1-dependent nuclear export of the adenovirus type 5 early region 1B 55-kDa protein augments oncogenic transformation of primary rat cells.
Endter C; Härtl B; Spruss T; Hauber J; Dobner T
Oncogene; 2005 Jan; 24(1):55-64. PubMed ID: 15480414
[TBL] [Abstract][Full Text] [Related]
19. Jab1 induces the cytoplasmic localization and degradation of p53 in coordination with Hdm2.
Oh W; Lee EW; Sung YH; Yang MR; Ghim J; Lee HW; Song J
J Biol Chem; 2006 Jun; 281(25):17457-17465. PubMed ID: 16624822
[TBL] [Abstract][Full Text] [Related]
20. p14ARF induces the relocation of HDM2 and p53 to extranucleolar sites that are targeted by PML bodies and proteasomes.
Kashuba E; Mattsson K; Klein G; Szekely L
Mol Cancer; 2003 Mar; 2():18. PubMed ID: 12685933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
